2019
DOI: 10.1590/1678-4324-2019180503
|View full text |Cite
|
Sign up to set email alerts
|

Pseudomonas Aeruginosa: Virulence Factors and Antibiotic Resistance Genes

Abstract: In this review, we explore some aspects of Pseudomonas aeruginosa virulence factors that are related to disease development in healthy organisms and resistance to antibiotics. This pathogen is one of the most clinically and epidemiologically important bacteria in Brazil, being the major cause of opportunistic infections. Among the virulence factors, biofilm formation acting of manner different in the organism. Furthermore, we review several P. aeruginosa genes that act in antimicrobial resistance, such as β-la… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
32
0
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(47 citation statements)
references
References 49 publications
1
32
0
3
Order By: Relevance
“…It is the leading cause of nosocomial infections such as urinary tract infections, surgical site infections, pneumonia, bacteremia and septicaemia 1 , 2 . It is one of the ESKAPE pathogens that is most medically and epidemiologically significant and has been implicated as a principal cause of chronic lung infections in cystic fibrosis (CF) patients and severe infections in burn victims 3 , 4 . The World Health Organization (WHO) has categorized P. aeruginosa as a critical priority pathogen, which needs urgent novel antibiotics intervention and was given a serious threat level due to multidrug resistance displayed to many antibiotics 5 , 6 .…”
Section: Introductionmentioning
confidence: 99%
“…It is the leading cause of nosocomial infections such as urinary tract infections, surgical site infections, pneumonia, bacteremia and septicaemia 1 , 2 . It is one of the ESKAPE pathogens that is most medically and epidemiologically significant and has been implicated as a principal cause of chronic lung infections in cystic fibrosis (CF) patients and severe infections in burn victims 3 , 4 . The World Health Organization (WHO) has categorized P. aeruginosa as a critical priority pathogen, which needs urgent novel antibiotics intervention and was given a serious threat level due to multidrug resistance displayed to many antibiotics 5 , 6 .…”
Section: Introductionmentioning
confidence: 99%
“…Pseudomonas are non-fermentative oxidase-positive, motile, aerobic Gram-negative rods belonging to the family Pseudomonadaceae, with a large genome of approximately 6.3 million base pairs (Mbp), encoding 5567 genes (1). Pseudomonas commonly colonizes hospital environment, equipment, and have remained a prominent cause of healthcare-associated infections (HAIs) (2).…”
Section: Introductionmentioning
confidence: 99%
“…Pseudomonas generally possesses several virulence factors including lipopolysaccharide, type IV pili, type III and VI secretion systems, alginate, exotoxin A, proteases, quorum sensing, generation of oxidants in the airways, formation of biofilm and pigments (1). Pseudomonas generally are intrinsically resistant to several antibiotics, and recently, more resistance from acquired sources is progressively increasing (5).…”
Section: Introductionmentioning
confidence: 99%
“…Background 3 P. aeruginosa is an opportunistic pathogen causing infections especially in immunocompromised patients. It is the leading cause of nosocomial infections such as urinary tract infections, surgical site infections, pneumonia, bacteremia and septicaemia [1][2][3] It is one of the ESKAPE pathogens that is most medically and epidemiologically significant and has been implicated as a principal cause of chronic lung infections in cystic fibrosis (CF) patients and severe infections in burn victims [4][5][6][7]. The World Health Organization (WHO) has categorized P. aeruginosa as a critical priority pathogen which needs urgent novel antibiotics intervention and has been given a serious threat level due to multidrug resistance displayed to many antibiotics [8,9].…”
mentioning
confidence: 99%